Deferred aflibercept

DRUG2 trials

Sponsors

Jaeb Center for Health Research

Conditions

Diabetic Macular EdemaDiabetic Retinopathy

Phase 3

Treatment for CI-DME in Eyes With Very Good VA Study

CompletedNCT01909791

Jaeb Center for Health ResearchDiabetic Macular Edema

Start: 2013-10-31End: 2018-09-11Updated: 2020-07-31

Anti-VEGF Treatment for Prevention of PDR/DME

CompletedNCT02634333

Jaeb Center for Health ResearchDiabetic Macular Edema, Diabetic Retinopathy

Start: 2016-01-31End: 2022-05-11Updated: 2023-06-18

Related Papers

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

JAMA2023-02-0753 citations

Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

JAMA Ophthalmology2021-03-30128 citations

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity

JAMA Ophthalmology2020-02-2044 citations

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity

JAMA2019-04-30282 citations